Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma: 10-year review in a tertiary referral center.
Wang
Tang Chuan
TC
Department of Otolaryngology Head and Neck Surgery, China Medical University Hospital, Taichung, Taiwan.
Hua
Chun Hun
CH
Lin
Ching Chia
CC
Tsou
Yung-An
YA
Tseng
Hsien Chang
HC
Tsai
Ming Hsui
MH
D000539:Alveolar Process / Q000473:pathology / Q000601:surgery*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000627:therapeutic use; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D008441:Maxillary Neoplasms / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D037981:Neck Dissection; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D009367:Neoplasm Staging; D010157:Palatal Neoplasms / Q000473:pathology / Q000601:surgery*; D021362:Palate, Hard / Q000473:pathology / Q000601:surgery*; D010160:Palate, Soft / Q000473:pathology; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012086:Reoperation; D012189:Retrospective Studies; D012307:Risk Factors; D016879:Salvage Therapy; D015996:Survival Rate; D013701:Temporal Bone / Q000473:pathology; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D002945:Cisplatin